AstraZeneca Pharma India Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 3,110.72 million compared to INR 2,361.27 million a year ago. Revenue was INR 3,194.45 million compared to INR 2,429.21 million a year ago. Net income was INR 523.7 million compared to INR 325.64 million a year ago. Basic earnings per share from continuing operations was INR 20.95 compared to INR 13.03 a year ago.
For the six months, sales was INR 6,065.38 million compared to INR 4,684.57 million a year ago. Revenue was INR 6,230.15 million compared to INR 4,793.67 million a year ago. Net income was INR 1,062.31 million compared to INR 527.17 million a year ago. Basic earnings per share from continuing operations was INR 42.49 compared to INR 21.09 a year ago.